Personalized therapy algorithms for type 2 diabetes: a phenotype-based approach by Ceriello A, Gallo M, Candido R, De Micheli A, Esposito K, Gentile S, Medea G

Get full text

Physical Health and Transition to Psychosis in People at Clinical High Risk by De Micheli, A, Provenzani, U, Krakowski, K, Oliver, D, Damiani, S, Brondino, N, McGuire, P, Fusar-Poli, P

Effects of benzodiazepine exposure on real-world clinical outcomes in individuals at clinical high risk for psychosis by Livingston, NR, De Micheli, A, McCutcheon, RA, Butler, E, Hamdan, M, Grace, AA, McGuire, P, Egerton, A, Fusar-Poli, P, Modinos, G

Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosis by Livingston, NR, Kiemes, A, Devenyi, GA, Knight, S, Lukow, PB, Jelen, LA, Reilly, T, Dima, A, Nettis, MA, Casetta, C, Agyekum, T, Zelaya, F, Spencer, T, De Micheli, A, Fusar-Poli, P, Grace, AA, Williams, SCR, McGuire, P, Egerton, A, Chakravarty, MM, Modinos, G

Connectome dysfunction in patients at clinical high risk for psychosis and modulation by oxytocin by Davies, C, Martins, D, Dipasquale, O, McCutcheon, RA, De Micheli, A, Ramella-Cravaro, V, Provenzani, U, Rutigliano, G, Cappucciati, M, Oliver, D, Williams, S, Zelaya, F, Allen, P, Murguia, S, Taylor, D, Shergill, S, Morrison, P, McGuire, P, Paloyelis, Y, Fusar-Poli, P